Suchergebnisse - "Y25LQ0H97D"

PubPharm (630)

1

Nafamostat mesylate decreases skin flap necrosis in a mouse model of type 2 diabetes by protecting the endothelial glycocalyx

enthalten in: Biochemical and biophysical research communications | 2024

von Fukuda, Y. | Okada, H. | Tomita, H. | +20

2

Organotypic lung tissue culture as a preclinical model to study host- influenza A viral infection : A case for repurposing of nafamostat mesylate

enthalten in: Tissue & cell | 2024

von Saglam-Metiner, P. | Yildiz-Ozturk, E. | Tetik-Vardarli, A. | +5

3

Nafamostat Reduces the Incidence of post-ERCP Pancreatitis : A Systematic Review and Meta-Analysis of Randomized Controlled Trials

enthalten in: Clinical pharmacology and therapeutics | 2024

von Horváth, I. | Kleiner, D. | Nagy, R. | +4

4

Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients : a two-centre observational study

enthalten in: BMC nephrology | 2024

von Kameda, S. | Maeda, A. | Maeda, S. | +5

5

Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japan

enthalten in: PloS one | 2024

von Shida, H. | Komamine, M. | Kajiyama, K. | +3

6

Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding : a retrospective single-center study

enthalten in: European journal of medical research | 2024

von Liu, D. | Zhao, J. | Xia, H. | +5

7

Prevention of vincristine-induced peripheral neuropathy by protecting the endothelial glycocalyx shedding

enthalten in: Biochemical and biophysical research communications | 2024

von Ohmura, K. | Kinoshita, T. | Tomita, H. | +7

8

Efficacy of nafamostat mesylate in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography : a systematic review and meta-analysis of randomized controlled trials

enthalten in: Scientific reports | 2023

von Narumi, K. | Okada, T. | Lin, Y. | +1

9

Drug repurposing for the treatment of COVID-19 : Targeting nafamostat to the lungs by a liposomal delivery system

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2023

von Reus, P. | Guthmann, H. | Uhlig, N. | +15

10

A Randomized Trial of Nafamostat for Covid-19

enthalten in: NEJM evidence | 2023

von Morpeth, S. | Venkatesh, B. | Totterdell, J. | +61

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[63]